secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2022-02-17T23:59:59+00:00
Accession:  0001683168-22-001119
Event type: regulatory
Sentiment:  negative
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharmacyte Biotech notifies Nasdaq of board independence non-compliance after director death
--------------------------------------------------------------------------------

- Board member Thomas C.K. Yuen died Feb 13, 2022; company notified Nasdaq Feb 15, 2022.
- Due to his death, majority of board no longer independent, violating Nasdaq Listing Rule 5605(b)(1).
- Company has automatic cure period; expects to regain compliance by appointing new independent director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316822001119/0001683168-22-001119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316822001119/pharmacyte_i8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-001119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer